Chemical Property of Ripasudil
Chemical Property:
- Boiling Point:497.2±55.0 °C(Predicted)
- PKA:9.70±0.40(Predicted)
- PSA:70.68000
- Density:1.293±0.06 g/cm3(Predicted)
- LogP:3.09390
- Storage Temp.:under inert gas (nitrogen or Argon) at 2–8 °C
- XLogP3:1.5
- Hydrogen Bond Donor Count:1
- Hydrogen Bond Acceptor Count:6
- Rotatable Bond Count:2
- Exact Mass:323.11037616
- Heavy Atom Count:22
- Complexity:482
- Purity/Quality:
-
99%, *data from raw suppliers
K-115 *data from reagent suppliers
Safty Information:
- Pictogram(s):
- Hazard Codes:
- MSDS Files:
-
SDS file from LookChem
Useful:
- Canonical SMILES:CC1CNCCCN1S(=O)(=O)C2=CC=CC3=CN=CC(=C32)F
- Isomeric SMILES:C[C@H]1CNCCCN1S(=O)(=O)C2=CC=CC3=CN=CC(=C32)F
- Recent ClinicalTrials:A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
- Recent EU Clinical Trials:A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and
- Recent NIPH Clinical Trials:Study for intraocular pressure elevation after glaucoma surgery
-
Description
Ripasudil (Glanatec TM, Kowa Pharmaceutical), a close derivative of fasudil, is another Rho kinase inhibitor approved in Japan at the end of 2014 for the treatment of glaucoma and ocular hypertensionwhen other therapeutic agents are not effective or cannot be administered. Additionally, ripasudil has been tested in diabetic retinopathy clinical trials and shown to promote corneal endothelial cell proliferation, endothelium regeneration, and wound healing.